Premilinary survival results and potential beneficiaries for locally advanced nasopharyngeal carcinoma treated with neoadjuvant chemotherapy followed by concurrent chemoradiotherapy.

被引：0
|
作者：
Feng, Mei
Lang, Jinyi
Li, Lu
Huang, Yecai
Xu, Peng
Qi, Yunxiang
Li, Fang
Wang, Weidong
机构：
[1] Sichuan Canc Hosp, Chengdu, Sichuan, Peoples R China
[2] Univ Elect Sci & Technol China, Sch Med, Sichuan Canc Hosp & Inst, Dept Radiat Oncol, Chengdu, Peoples R China
[3] Sichuan Canc Hosp & Inst, Chengdu, Sichuan, Peoples R China
[4] Shandong Canc Hosp & Inst, Dept Radiat Oncol, Chengdu, Sichuan, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.6030
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6030
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Preliminary outcome of the survival rate and possible prognostic factors for locally advanced nasopharyngeal carcinoma patients treated with neoadjuvant chemotherapy followed by concurrent chemoradiotherapy.
    Lang, Jin Yi
    Feng, Mei
    Yuan, Mengzhen
    Huang, Yecai
    Luo, Yangkun
    Fan, Zhixuan
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
    Setakornnukul, Jiraporn
    Thephamongkhol, Kullathorn
    BMC CANCER, 2018, 18
  • [3] Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
    Jiraporn Setakornnukul
    Kullathorn Thephamongkhol
    BMC Cancer, 18
  • [4] neo adjuvant chemotherapy followed by concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma
    Abdou, Sara
    Benzerouale, Ouail
    El Gueddari, Rania
    Taouchikht, Mouna
    Fares, Houda
    Hassnaoui, Imane
    Ngbwa, Edith Tatiana
    Nouni, Karima
    Lachgar, Amine
    Elkacemi, Hanan
    Kebdani, Tayeb
    Hassouni, Khalid
    RADIOTHERAPY AND ONCOLOGY, 2024, 192 : S249 - S250
  • [5] Neoadjuvant chemotherapy combined with concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone on locally advanced nasopharyngeal carcinoma
    Liu, H.
    Ding, X. R.
    Song, Y. Q.
    Jiang, C.
    Zhong, X. M.
    Hui, H. X.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2020, 34 (06): : 2115 - 2119
  • [6] Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy with or without nimotuzumab in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study
    Yang, Zhi
    Zuo, Quan
    Liu, Rong
    Wu, Hui
    Xiong, Li
    Jia, Jieqi
    Xiang, Zhibi
    BMC CANCER, 2023, 23 (01)
  • [7] Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy with or without nimotuzumab in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study
    Zhi Yang
    Quan Zuo
    Rong Liu
    Hui Wu
    Li Xiong
    Jieqi Jia
    Zhibi Xiang
    BMC Cancer, 23
  • [8] Early Results of the Survival Results and Possible Prognostic Factors for Locally Advanced Nasopharyngeal Carcinoma Patients Treated With Neoadjuvant Chemotherapy Followed With Concurrent Chemoradiation Therapy
    Lang, J.
    Feng, M.
    Yuan, M.
    Fan, Z.
    Luo, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E320 - E320
  • [9] Tislelizumab plus neoadjuvant chemotherapy and concurrent chemoradiotherapy versus neoadjuvant chemotherapy and concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma: A retrospective study
    He, Jiaqi
    Luo, Guoqing
    Liu, Shen
    Chen, Lingli
    Chen, Zihong
    Zhang, Bing
    Lin, Jiong
    Qin, Wenyi
    Li, Haiwen
    Zhou, Haideng
    Yu, Ying
    Zhan, Dechao
    Yang, Donghong
    Luo, Haiqing
    TRANSLATIONAL ONCOLOGY, 2024, 48
  • [10] Results of patients of locally advanced nasopharyngeal carcinoma treated with neoadjuvant chemotherapy or upfront concurrent chemoradiotherapy: A regional cancer centre experience
    Patel, P. N.
    Goyal, S.
    Suryanarayana, U.
    Anand, A.
    Panchal, H.
    Patel, A.
    Parikh, S.
    ANNALS OF ONCOLOGY, 2017, 28
12345